Tag | Content |
---|
EnhancerAtlas ID | HS183-11009 |
Organism | Homo sapiens |
Tissue/cell | T47D-MTVL |
Coordinate | chr8:38272410-38273380 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr8:38272605-38272623 | CGCTCCTCCCTTCCTTCC | - | 7.1 | TFAP2A | MA0003.3 | chr8:38273136-38273147 | TGCCTGAGGCT | - | 6.32 | ZNF263 | MA0528.1 | chr8:38272420-38272441 | TGAGGAAGGAGGAAGGGAGAG | + | 6.11 | ZNF263 | MA0528.1 | chr8:38272427-38272448 | GGAGGAAGGGAGAGCGGGAGG | + | 6.3 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_00420 | chr8:38271029-38272663 | Adipose_Nuclei | SE_68700 | chr8:38270438-38272954 | H9 | SE_68700 | chr8:38273081-38273763 | H9 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH08I038413 | chr8 | 38271030 | 38272663 | GH08I038415 | chr8 | 38273082 | 38273763 |
|
Enhancer Sequence | GTGTATGCAC TGAGGAAGGA GGAAGGGAGA GCGGGAGGCG GGGAGGTGAG GGAGCTGGAA 60 GGCTCTGGGC GGCCGCCACC CATGCAACTA GCCGACTTGT CTCATAGAAC TTCTGCCACA 120 CTGCTCTGCC CCCCGAACCT TTGCTTTCCC TCTTCTAACA TTCTCTGCCA GCTCCAGGCT 180 TCTCATCACA GCAAGCGCTC CTCCCTTCCT TCCCCAAAGA CTGGCCCCTT ATGCCTCTGC 240 TGCGTCTGCA GCGATGCATG CTCCTAGGTC CTGCCTCCCA GCACAGCAAG TCCACATGGG 300 GCTGGGCTCA AACCAGGCCA GCCCTTACAC ACCAAACACT GCACTCAACA CTCACAGACA 360 GTTTCATTTT ATCTTCATAA CAATTCTACA ACAGGTATTG TTATACTTTA TTTTCTTTTG 420 AGACAGGGCC TTGCTCTGTC GCCCCGGCTG GGGTGCAGTG GTGTGATCAT GGCTCAGTGC 480 AGCCTCAAAC TCTTGGGCTC AAGCTAGCCT CCCACCTCAG CCTCCCGAGT AGCTGGGACT 540 ATCGGCACGC ACTACCACAC CCAGCTAATT TTTTAATTTT TTTTTTTTTT TTAAAGACGG 600 GGTTTCAATA TATTGCCCAA CCTGGTCTCA CACTCCTGAG CTCAAGCAAT CCTCCCGCCT 660 TGGCCACTGC ACCCAGCTGA TATTATTATT ATTTTGTATT TGAAGAATTT TAAGATGCTA 720 AGTAGCTGCC TGAGGCTACG CAGAAAGTGG CAGTGCACAG ATCGGACCCT GCATCAGTCT 780 GACCCCAAGG CCACCTGGCT ACACTGGTGC TCCTGACTCT GCAGTTCCCA GAGAGCCTAA 840 GACAACACAC AGGGCACACA GGGCCAGTGC TCAGTGCATC CACAACGCCA CCACAAGATG 900 ATAAGTCACA GGCTGGAAGA CTAGGGGGGC TCTGTTCCCA CCCTGGCATT ACCCAGGGGA 960 GCCTTCAGGT 970
|